Dr. Gedminas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
BT 1327
Iowa City, IA 52242Phone+1 319-353-6393
Education & Training
- Children’s Hospital of PhiladelphiaFellowship, Pediatric Solid Tumor Oncology , 2019 - 2020
- Corewell Health Helen DeVos Children's Hospital/Michigan State UniversityFellowship, Pediatric Hematology/Oncology, 2016 - 2019
- Advocate Health CareResidency, 2013 - 2016
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2013
Certifications & Licensure
- IA State Medical License 2022 - 2025
- PA State Medical License 2019 - 2022
- MI State Medical License 2016 - 2020
- IL State Medical License 2013 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 28 citationsTrabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner.Matt Harlow, Maggie H. Chasse, Elissa Boguslawski, Katie M. Sorensen, Jenna M. Gedminas
Clinical Cancer Research. 2019-06-01 - 33 citationsDesmoplastic small round cell tumor is dependent on the EWS-WT1 transcription factor.Jenna M. Gedminas, Maggie H. Chasse, Mitchell McBrairty, Ian Beddows, Susan M. Kitchen-Goosen
Oncogenesis. 2020-04-28 - 10 citationsLurbinectedin Inhibits the EWS-WT1 Transcription Factor in Desmoplastic Small Round Cell Tumor.Jenna M Gedminas, Rebecca Kaufman, Elissa A Boguslawski, Amy C Gross, Marie Adams
Molecular Cancer Therapeutics. 2022-08-02
Books/Book Chapters
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: